Navigation Links
Scientists ID New Biomarker for Prostate Cancer
Date:3/25/2009

Study finds cleaved galectin-3 may serve as treatment target against disease progression

WEDNESDAY, March 25 (HealthDay News) -- A newly identified marker for prostate cancer progression may also offer a new target for treatment, University of Michigan researchers say.

Previous research has found that decreased levels of the marker galectin-3 are linked with neoplastic progression in prostate cancer. However, increased levels of galectin-3 are believed to be associated with tumorigenicity in a number of other tumor types.

The University of Michigan team believed this difference was due to the fact that galectin-3 was cleaved during prostate cancer progression. Their study found that cleaved galectin-3 is present in a late-stage prostate cancer and that reducing levels of galectin-3 inhibited development of metastatic prostate cancer.

The findings suggest that cleaved galectin-3 may serve as a diagnostic marker and treatment target for prostate cancer progression.

The study shows "that galectin-3 is cleaved during the progression of prostate cancer and might be associated with metastasis, cell growth and tumorigenicity. Expression of intact versus cleaved galectin-3 thus might be used as a marker for prognosis of prostate cancer and a therapeutic target for the treatment of prostate cancer," wrote study author Avraham Raz and colleagues.

The study appears in the April issue of The American Journal of Pathology.

More information

The American Cancer Society has more about prostate cancer.



-- Robert Preidt



SOURCE: The American Journal of Pathology, news release, March 25, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Herpes: Scientists find cellular process that fights virus
2. New book chronicles the journeys of women physicians and scientists to fighting cancer
3. University of Washington scientists one step closer to stopping bone loss during spaceflight
4. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
5. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
6. Scientists trial device to treat chemotherapy-related nausea
7. Scientists closer to understanding how to control high blood sugar
8. First Treatment for Muscular Dystrophy in Sight: Scientists Harness Exon-Skipping in Large Animal to Successfully Treat Duchenne Muscular Dystrophy
9. First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
10. Scientists find gene that modifies severity of cystic fibrosis lung disease
11. UCI scientists to study brain region linked to autism, schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists ID New Biomarker for Prostate Cancer
(Date:1/16/2017)... Louis, MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of ... here , This year’s influenza shot seems to be having no effect on ... area, at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... CITY, UT (PRWEB) , ... January 16, 2017 , ... ... disease not only to treat, but to test for, as well. The money spent ... billion every year.(1) Doctors in the U.S. screen patients for cancer more than in ...
(Date:1/15/2017)... York, NY (PRWEB) , ... January 15, 2017 , ... ... strategic accounts in the United States for the asthma & allergy friendly mark. This ... America to independently test and identify consumer products to be more suitable for the ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed slideshow ... ease," said Christina Austin - CEO of Pixel Film Studios. , On Tour’s ... the style and animation of their slideshows. Place each slide on top of another ...
(Date:1/15/2017)... ... January 15, 2017 , ... The ... is pleased to announce that it will be assisting HackensackUMC Mountainside with its ... Glen Ridge townships, servicing all surrounding towns. The firm will be working closely ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... -- This morning, Stock-Callers.com draws attention to ... at yesterday,s closing bell: Clovis Oncology Inc. (NASDAQ: ... GALE ), and ACADIA Pharmaceuticals Inc. (NASDAQ: ... to develop technologies and products that combat debilitating and ... use less and cleaner energy, and provide safer, cleaner ...
(Date:1/13/2017)... -- The 2016 election resulted in a big ... in favor of legalizing cannabis for recreational use, including ... U.S. In addition, the state of Colorado ... sales. The ArcView Group has published an updated research report ... in the U.S. last year reached $6.7 billion, a growth of ...
(Date:1/13/2017)... NEW YORK , Jan. 12, 2017 /PRNewswire-USNewswire/ ... type 1 diabetes (T1D) research, is pleased to ... advocacy efforts, the Centers for Medicare & Medicaid ... devices approved by the FDA for use in ... a significant step toward making them eligible for ...
Breaking Medicine Technology: